Cargando…

Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome

BACKGROUND: Currently, remnant cholesterol (RC), lipoprotein(a) [Lp(a)], and inflammation are considered the principal residual cardiovascular risk (RCVR) factors. This study sought to evaluate the combined impact of RC, Lp(a), and inflammation on prognosis of statin-treated patients with chronic co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hui-Hui, Guo, Yuan-Lin, Zhu, Cheng-Gang, Wu, Na-Qiong, Gao, Ying, Xu, Rui-Xia, Dong, Qian, Qian, Jie, Dou, Ke-Fei, Li, Jian-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134647/ https://www.ncbi.nlm.nih.gov/pubmed/35619146 http://dx.doi.org/10.1186/s12967-022-03448-x

Ejemplares similares

Nonsurgical Treatment of the Commonest Form of Deafness
por: Cott, George F.
Publicado: (1901)

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
por: Baratta, Francesco, et al.
Publicado: (2023)

Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
por: Heo, Ji Hye, et al.
Publicado: (2023)

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
por: Hu, Xiangming, et al.
Publicado: (2022)

Contribution of Remnant Cholesterol to Coronary Atherosclerosis
por: Ohmura, Hirotoshi
Publicado: (2022)

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies
por: Joshi, Parag H., et al.
Publicado: (2016)

Small Bowel Volvulus — The Commonest Abdominal Emergency in Nepal
por: McDonald, I. O., et al.
Publicado: (1980)

Lectures on Aural Catarrh; or the Commonest Forms of Deafness and Their Cure
Publicado: (1872)

The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes
por: Cao, Ye-Xuan, et al.
Publicado: (2020)

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
por: Chinwong, Dujrudee, et al.
Publicado: (2015)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Im, Jihaeng, et al.
Publicado: (2021)

Why is Intradialytic Hypotension the Commonest Complication of Outpatient Dialysis Treatments?
por: Davenport, Andrew
Publicado: (2022)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention
por: Seo, Suk Min, et al.
Publicado: (2011)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population
por: Shi, Liu, et al.
Publicado: (2023)

Drink Driving as the Commonest Drug Driving—A Perspective from Europe
por: Allsop, Richard
Publicado: (2020)

Postprandial Hyperlipidemia and Remnant Lipoproteins
por: Masuda, Daisaku, et al.
Publicado: (2017)

Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population
por: Cheang, Iokfai, et al.
Publicado: (2022)

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins
por: Fox, Kathleen M., et al.
Publicado: (2017)

Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients
por: Nagamine, Takahiko
Publicado: (2008)

High Levels of Remnant Lipoprotein Cholesterol Is a Risk Factor for Large Artery Atherosclerotic Stroke
por: Kim, Jeong-Yeon, et al.
Publicado: (2011)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance
por: Chen, Jin, et al.
Publicado: (2020)

Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
por: Chin, Justin, et al.
Publicado: (2020)

Gastrointestinal and Urinary Tract Endometriosis: A Review on the Commonest Locations of Extrapelvic Endometriosis
por: Charatsi, Dimitra, et al.
Publicado: (2018)

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022)

High Remnant Cholesterol Level Potentiates the Development of Hypertension
por: Chen, Ming-Ming, et al.
Publicado: (2022)

Remnant cholesterol but not LDL cholesterol is associated with 5-year bleeding following percutaneous coronary intervention
por: Li, Jiawen, et al.
Publicado: (2023)

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes
por: Jin, Jing-Lu, et al.
Publicado: (2022)

Significance of Circulating Remnant Lipoprotein Cholesterol Levels Measured by Homogeneous Assay in Patients with Type 2 Diabetes
por: Matsushima-Nagata, Kazumi, et al.
Publicado: (2023)

Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease
por: Hong, Li-Feng, et al.
Publicado: (2017)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

Allometric equation for Raphia laurentii De Wild, the commonest palm in the central Congo peatlands
por: Bocko, Yannick Enock, et al.
Publicado: (2023)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Familial Resemblance in Low‐Density Lipoprotein Cholesterol Response to Statins in the Danish Population
por: Corn, Giulia, et al.
Publicado: (2022)

Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
por: Zhao, Yuqi, et al.
Publicado: (2023)

Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease
por: Zou, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_klvh18os8cbu1q4oigui7359tr